These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26034512)

  • 1. Insulin resistance by homeostasis model assessment in HIV-infected patients on highly active antiretroviral therapy: cross-sectional study.
    Guillen MA; Mejia FA; Villena J; Turin CG; Carcamo CP; Ticse R
    Diabetol Metab Syndr; 2015; 7():49. PubMed ID: 26034512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy.
    Palacios R; Merchante N; Macias J; González M; Castillo J; Ruiz J; Márquez M; Gómez-Mateos J; Pineda JA; Santos J
    Antivir Ther; 2006; 11(4):529-35. PubMed ID: 16856627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy.
    Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Choi JY; Song YG; Lee HC; Kim JM
    Metabolism; 2009 Nov; 58(11):1523-9. PubMed ID: 19501863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy.
    Addy CL; Gavrila A; Tsiodras S; Brodovicz K; Karchmer AW; Mantzoros CS
    J Clin Endocrinol Metab; 2003 Feb; 88(2):627-36. PubMed ID: 12574192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of insulin resistance among patients attending the HIV clinic in a Nigerian tertiary hospital.
    Dada AO; Oshodi TT; Ajie IO; Onyenekwu CP
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S607-S610. PubMed ID: 28462827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overweight HIV patients with abdominal fat distribution treated with protease inhibitors are at high risk for abnormalities in glucose metabolism - a reason for glycemic control.
    Blass SC; Ellinger S; Vogel M; Ingiliz P; Spengler U; Stehle P; von Ruecker A; Rockstroh JK
    Eur J Med Res; 2008 May; 13(5):209-14. PubMed ID: 18559303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand.
    Lee B; Aurpibul L; Sirisanthana V; Mangklabruks A; Sirisanthana T; Puthanakit T
    HIV Med; 2009 Feb; 10(2):72-8. PubMed ID: 19018877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome.
    Gazzaruso C; Bruno R; Garzaniti A; Giordanetti S; Fratino P; Sacchi P; Filice G
    J Hypertens; 2003 Jul; 21(7):1377-82. PubMed ID: 12817187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Molecular Weight (HMW): total adiponectin ratio is low in hiv-infected women receiving protease inhibitors.
    Omar F; Dave JA; King JA; Levitt NS; Pillay TS
    BMC Clin Pathol; 2014; 14(1):46. PubMed ID: 25580091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus.
    Grinspoon SK
    Am J Med; 2005 Apr; 118 Suppl 2():23S-28S. PubMed ID: 15903292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
    Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism.
    Samaras K; Wand H; Law M; Emery S; Cooper DA; Carr A
    Curr HIV Res; 2009 Jul; 7(4):454-61. PubMed ID: 19601783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome.
    Barbaro G
    Curr Pharm Des; 2007; 13(21):2208-13. PubMed ID: 17627554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance in HIV-infected men and women in the nutrition for healthy living cohort.
    Jones CY; Wilson IB; Greenberg AS; Shevitz A; Knox TA; Gorbach SL; Spiegelman D; Jacobson DL; Wanke C
    J Acquir Immune Defic Syndr; 2005 Oct; 40(2):202-11. PubMed ID: 16186739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
    Loko MA; Bani-Sadr F; Winnock M; Lacombe K; Carrieri P; Neau D; Morlat P; Serfaty L; Dabis F; Salmon D;
    J Viral Hepat; 2011 Jul; 18(7):e307-14. PubMed ID: 21692942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children.
    Bitnun A; Sochett E; Babyn P; Holowka S; Stephens D; Read S; King SM
    AIDS; 2003 Jun; 17(9):1319-27. PubMed ID: 12799553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy.
    Estrada V; Martínez-Larrad MT; González-Sánchez JL; de Villar NG; Zabena C; Fernández C; Serrano-Ríos M
    Metabolism; 2006 Jul; 55(7):940-5. PubMed ID: 16784968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study.
    Tien PC; Schneider MF; Cole SR; Levine AM; Cohen M; DeHovitz J; Young M; Justman JE
    J Acquir Immune Defic Syndr; 2008 Dec; 49(4):369-76. PubMed ID: 19186350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
    Vigouroux C; Maachi M; Nguyên TH; Coussieu C; Gharakhanian S; Funahashi T; Matsuzawa Y; Shimomura I; Rozenbaum W; Capeau J; Bastard JP
    AIDS; 2003 Jul; 17(10):1503-11. PubMed ID: 12824788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.